All-Cause, Stroke-, and Bleed-Specific Healthcare Costs: Comparison among Patients with Non-Valvular Atrial Fibrillation (NVAF) Newly Treated with Dabigatran or Warfarin

OBJECTIVE: Our objective was to compare all-cause and stroke- and bleed-specific healthcare costs among patients with non-valvular atrial fibrillation (NVAF) treated with dabigatran or warfarin. METHODS: Administrative claims data from the MarketScan(®) Databases for 2009–2014 were used. Patients wi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Am J Cardiovasc Drugs
Hoofdauteurs: Gilligan, Adrienne M., Gandhi, Pranav, Song, Xue, Wang, Cheng, Henriques, Caroline, Sander, Stephen, Smith, David M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer International Publishing 2017
Onderwerpen:
Original Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5701952/
https://ncbi.nlm.nih.gov/pubmed/28795348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40256-017-0244-1
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items